Over 10 years experience of Traceability Solutions
By pharmatrax
Category: Technoloy
No Comments Researchers at McMaster University have invented a stable, affordable way to store fragile vaccines for weeks at a time at temperatures up to 40C, opening…
By pharmatrax
Category: Technoloy
No Comments Demographic shifts and the rise of tech-led competition are applying pressure to the costs and margins of the world of healthcare and pharmaceuticals, while regulatory…
By pharmatrax
Category: Technoloy
No Comments Shanghai will continue its strategic and policy support to transform the eastern city into a hub for science and technology innovation with a focus on…
By pharmatrax
Category: Technoloy
No Comments When testing for such as lung cancer disease, doctors know that tissue biopsies are necessary and potentially life-saving, though the procedures used to gather tissue…
By pharmatrax
Category: Technoloy
No Comments Selecting a single CRO partner that can take CNS compounds from functional screening in vitro through in vivo and beyond Today, 50 million people worldwide…
By pharmatrax
Category: Technoloy
No Comments From sensors and software to data-based services throughout production, Industry 4.0 solutions are opening new potentials in terms of transparency, quality, safety and efficiency. In…
By pharmatrax
Category: Technoloy
No Comments On December 13, 2018 the U.S. Food and Drug Administration (FDA) released the final version of its guidance titled, “Data Integrity and Compliance with Drug…
By pharmatrax
Category: Technoloy
No Comments Real-time data insights help both pharma companies and contract manufacturers meet regulatory requirements while ensuring high production standards. Pharmaceutical companies are locked in a perpetual…
By pharmatrax
Category: Technoloy
No Comments The Food and Drug Administration has approved a pilot to study the use of healthcare blockchain to track and verify specialty prescription drugs. April 29,…
By pharmatrax
Category: Technoloy
No Comments IBM Watson Health is diverting resources from its AI drug discovery service due to insufficient demand and poor financial performance, according to industry reports. IBM…